The Lancet

The use of rapid lateral flow antigen testing (LFT) for SARS-CoV-2 has been questioned123 with uncorroborated4 reports of poor LFT sensitivity. The debate surrounding the use of the Innova Lateral Flow SARS-CoV-2 Antigen Test in the UK risks confusing policy makers internationally and potentially stalling deployment of LFTs in other countries.5 As scientists and health professionals evaluating some of the world’s largest pilots of LFT, we wish to challenge those interpretations and clarify the evidence on how such testing might be used to detect SARS-CoV-2 in minutes and improve COVID-19 control measures.

READ LANCET ARTICLE HERE > https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00425-6/fulltext

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *